Clik here to view.
Zoll’s Q2 profits soar 105 percent
Zoll Medical Corp. (NSDQ:ZOLL) posted strong second-quarter results, reporting a 15.5 percent increase in revenues and a 105 percent surge in Q2 profits. The Billerica, Mass.-based resuscitation...
View ArticleClik here to view.
FDA a step closer to stiffening regulations on defibrillators
A Food & Drug Administration advisory committee’s support for stiffer controls on automated external defibrillators means the devices could be slated for the agency’s toughest regulatory process....
View ArticleClik here to view.
GOP hopeful Rick Perry’s stem cell decision causes a clamor | MassDevice.com...
MASSDEVICE ON CALL — Headlines are abuzz over GOP candidate Rick Perry’s unusual decision to undergo a controversial and perhaps legally problematic stem cell therapy to treat his bad back. Perry...
View ArticleClik here to view.
Zoll Medical CEO discusses recent stock woes
It’s been a rough end of the summer on The Street for Zoll Medical Corp. (NSDQ:ZOLL), which has seen its share price cut nearly in half over the past six weeks. On August 1 shares of the Chelmsford,...
View ArticleClik here to view.
ZOLL: Reimbursement change for LifeVest would hit only 8 percent of sales
A change to the way the LifeVest is reimbursed by Medicare would affect just 8 percent of Zoll Medical Corp.’s (NSDQ:ZOLL) total sales, CEO Richard Packer told a group of analysts Wednesday. Speaking...
View ArticleClik here to view.
UPDATE: Medtronic finally unloads Physio-Control
Less than a month after new CEO Omar Ishrak signaled Medtronic’s (NYSE:MDT) continued interest in selling its troublesome Physio-Control resuscitation business, the company found a buy ready to put...
View ArticleClik here to view.
Zoll shares spike 23 percent on record 2011 sales and earnings | Earnings...
Zoll reported record numbers in its top and bottom line for fiscal year 2011, sending its stock up 23 percent overnight. Zoll shares were trading at $44.35 in the early afternoon today, up from last...
View ArticleClik here to view.
Zoll soars on news of $2.2B Asahi Kasei acquisition
Zoll Medical (NSDQ:ZOLL) is winning a lot of Wall Street love this morning on the news of a $2.21 billion cash offer from Asahi Kasei Corp. (TYO:3407). ZOLL shares jumped 23.5% to $92.74 in morning...
View ArticleClik here to view.
Asahi Kasei closes $2.3B tender for Zoll Medical
Chelmsford, Mass.-based resuscitation device maker Zoll Medical (NSDQ:ZOLL) sealed the deal with Japan’s Asahi Kasei Corp. (TYO:3407) over the weekend. Asahi, through a U.S. subsidiary, paid $93...
View ArticleClik here to view.
Patient safety: Zoll CEO makes the pledge to share data
Medical device maker Zoll Medical is among the 1st medical device companies to sign on to the patient safety and medical device data pledge proposed by Masimo (NSDQ:MASI) founder & CEO Joe Kiani...
View ArticleClik here to view.
GE Healthcare announces Class I recall of infant resuscitation kits
The FDA gave Class I status to GE Healthcare’s (NYSE:GE) recall of upgrade kits for some infant warmers over concerns that mislabeling in the kits may result in neonatal patients getting the wrong...
View ArticleClik here to view.
Zoll lands FDA clearance for automated external defibrillator
Asahi Kasei (TYO:3407) subsidiary Zoll Medical won 510(k) clearance from the FDA for its fully-automated AED Plus device, which improves on the former semi-automatic model. The new automated external...
View ArticleClik here to view.
Another Class I recall for GE Healthcare
Federal healthcare regulators put their highest-risk Class I label on a new warning issued over GE Healthcare’s (NYSE:GE) Giraffe and Panda neonatal infant warmers and resuscitation systems. The...
View ArticleClik here to view.
Judge tosses latest Zoll suit against Philips
A federal judge yesterday tossed a patent infringement lawsuit between defibrillator rivals Zoll Medical and Philips Healthcare (NYSE:PHG), the latest development in their 4-year-old dispute over...
View ArticleClik here to view.
Advanced Circulatory Systems lands a date with the FDA
Minnesota medical device maker Advanced Circulatory Systems won a panel date with the FDA to review a PMA bid for its ResQCPR resuscitation systems. The FDA’s Circulatory System Devices Panel will...
View ArticleClik here to view.
Press Release: Circulatory System Devices Advisory Panel Provides Favorable...
Advanced Circulatory, makers of medical devices providing Intrathoracic Pressure Regulation (IPR) Therapy, will continue to work with the Food and Drug Administration (FDA) on a pathway to premarket...
View ArticleClik here to view.
FDA panel votes ‘yes’ on Advanced Circulatory’s new CPR tech
The FDA’s Circulatory System Devices Advisory Panel voted this month to recommend approval for Advanced Circulatory’s ResQCPR system for use during emergency CPR to help increase survival and minimize...
View ArticleClik here to view.
Zoll lands Japanese OK for R Series monitor/defibrillator
Zoll Medical said today that it won Shonin approval from the Japanese Ministry of Health, Labor & Welfare for its R Series combination monitor and automated external defibrillator. Zoll said its...
View ArticleClik here to view.
Zoll Medical, Philips withdraw appeal in defibrillator patent spat
A federal appeals court today granted a joint motion by defibrillator rivals Zoll Medical and Philips Healthcare (NYSE:PHG) to withdraw the appeal of Zoll’s loss in a patent infringement lawsuit. A...
View ArticleClik here to view.
Appeals court denies Zoll challenge to Philips AED patents
A federal appeals court this week shut down Zoll Medical‘s bid to force the U.S. Patent & Trademark Office to review 8 patents owned by Philips Healthcare (NYSE:PHG), ruling that it lacks the...
View Article